DexCom, Inc. - Common Stock (NQ:DXCM)

68.47 -1.69 (-2.40%)

Streaming Delayed Price Updated: 1:20 PM EST, Feb 10, 2026 Add to My Watchlist

Price and Volume

Volume	4,770,122
Open	70.18
Bid (Size)	68.44 (100)
Ask (Size)	68.51 (700)
Prev. Close	70.16
Today's Range	68.31 - 70.34
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore

February 08, 2026

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds

February 05, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Performance

YTD	+2.9%	+2.9%
1 Month	-3.5%	-3.5%
3 Month	+24.9%	+24.9%
6 Month	-12.0%	-12.0%
1 Year	-22.4%	-22.4%

More News

Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management

February 04, 2026

From Dexcom, Inc.

Via Business Wire

DexCom Inc. (NASDAQ:DXCM) Combines Strong Fundamentals with Bullish Chart Pattern ↗

January 20, 2026

Via Chartmill

3 Profitable Stocks for Long-Term Investors

January 28, 2026

Via StockStory

Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.

January 27, 2026

From DexCom, Inc.

Via Business Wire

2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore

January 26, 2026

Via StockStory

Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness

January 22, 2026

Via MarketMinute

Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat

January 22, 2026

Via MarketMinute

1 Growth Stock Down 19% to Buy Right Now ↗

January 21, 2026

Via The Motley Fool

Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights

January 15, 2026

From Halper Sadeh LLC

Via Business Wire

Top S&P500 movers in Monday's session ↗

January 12, 2026

Via Chartmill

What's going on in today's session: S&P500 movers ↗

January 12, 2026

Via Chartmill

Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

January 12, 2026

From DexCom, Inc.

Via Business Wire

DexCom (DXCM) Stock Trades Down, Here Is Why

January 08, 2026

Via StockStory

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

January 07, 2026

From DexCom, Inc.

Via Business Wire

3 Nasdaq 100 Stocks Worth Your Attention

January 04, 2026

Via StockStory

The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature

January 01, 2026

Via PredictStreet

2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky

December 31, 2025

Via StockStory

2 Growth Stocks to Buy For 2026 and Beyond ↗

December 30, 2025

Via The Motley Fool

DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗

December 30, 2025

Via Chartmill

DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm

December 26, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

December 26, 2025

From Schall Law

Via GlobeNewswire

The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare

December 24, 2025

Via MarketMinute

1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid

December 22, 2025

Via StockStory

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 68.47

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 02/10/26 01:20 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 26.71B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 27B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.